5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.53▲ | 9.54▲ | 9.52▲ | 9.65▲ | 8.44▲ |
MA10 | 9.49▲ | 9.51▲ | 9.54▲ | 9.09▲ | 7.55▲ |
MA20 | 9.60▲ | 9.63▲ | 9.68▲ | 8.49▲ | 8.31▲ |
MA50 | 9.69▲ | 9.49▲ | 9.17▲ | 7.58▲ | 8.45▲ |
MA100 | 9.35▲ | 9.18▲ | 8.83▲ | 8.47▲ | 11.30▼ |
MA200 | 9.09▲ | 8.51▲ | 7.79▲ | 7.04▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | -0.016▼ | -0.045▼ | 0.138▲ | 0.286▲ |
RSI | 56.941▲ | 56.607▲ | 56.717▲ | 65.439▲ | 56.581▲ |
STOCH | 59.596 | 48.567 | 33.293 | 39.625 | 47.478 |
WILL %R | 0.000▲ | -9.302▲ | -23.529▲ | -61.654 | -42.710 |
CCI | 129.035▲ | 86.106 | 32.974 | 69.172 | 111.417▲ |
CDL | $CRVO Engulfing Candlestick Pattern Detected | Set Alert |
Sunday, August 10, 2025 08:04 AM
NasdaqCM:CRVO 1 Year Share Price vs Fair Value Explore CervoMed's Fair Values from the Community and select ...
|
Tuesday, August 05, 2025 05:10 AM
CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will participate in a fireside ...
|
Monday, July 28, 2025 09:30 AM
Shares in CervoMed were up 6% Monday lunchtime after the US company announced positive 32-week data from the extension phase of the Phase IIb RewinD-LB trial showing that oral neflamapimod continues ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 9.30 | 9.88 | 9.105 | 9.85 | 177,708 |
07/08/25 | 9.45 | 9.93 | 9.29 | 9.34 | 151,318 |
06/08/25 | 9.79 | 9.97 | 9.56 | 9.69 | 206,070 |
05/08/25 | 9.27 | 10.19 | 9.10 | 10.05 | 281,212 |
04/08/25 | 9.00 | 9.97 | 8.76 | 9.33 | 363,273 |
01/08/25 | 8.07 | 9.00 | 7.8697 | 8.83 | 221,626 |
31/07/25 | 8.19 | 8.8469 | 7.90 | 8.25 | 292,707 |
30/07/25 | 8.73 | 8.9868 | 8.24 | 8.50 | 296,674 |
29/07/25 | 8.95 | 9.4199 | 8.27 | 8.42 | 603,482 |
28/07/25 | 12.04 | 13.13 | 8.59 | 8.67 | 12,196,426 |
|
|
||||
|
|
||||
|
|